Skip to main content

Table 3 Correlation of HR-/HER2- subgroups with pCR (univariate logistic regression analysis)

From: Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

  n events % pCR OR 95% CI p
HR-/HER2- subgroups
Ki67 (per 10%)
29 7 - 1.92 1.21-3.04 0.006
CK5/6 30 8     
   negative 24 5 20.8 1.00   
   positive 6 3 50.0 3.80 0.58-24.88 0.127
COX-2 26 7     
   negative 9 3 33.3 1.00   
   positive 17 4 23.5 0.62 0.10-3.66 0.593
YB-1 30 7     
   negative 22 5 22.7 1.00   
   positive 8 2 25.0 1.13 0.17-7.47 0.896
  1. OR: odds ratio; CI: confidence interval.